Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Bristol Myers Squibb Co (BMY)

2015-02-28@13:00:04 ET
Drug manufacturers take to outsourcing (ABW)

2015-02-27@14:37:37 ET
Potential Bristol Myers (BMY) Trade Has 5.69% Downside Protection (FBM)

2015-02-27@13:34:00 ET
U.S. Food and Drug Administration Accepts Biologics Licensing Application for Opdivo (nivolumab) for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer (BIZ)

2015-02-27@06:48:44 ET
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Pipeline Review 2015 - 26 Companies & 40 Drug Profiles (MTO)

2015-02-27@06:48:34 ET
Hodgkin Lymphoma Therapeutics Pipeline Review 2015 - Analysis of 26 Companies (MTO)

2015-02-27@05:11:42 ET
Bristol-Myers announces encouraging results from Phase III HIV-HCV trial (DTM)

2015-02-27@05:11:32 ET
Bristol-Myers announces encouraging data from HIV-1 study (DTM)

2015-02-27@03:26:52 ET
Global Congestive Heart Failure Drugs Market 2015-2019 with AstraZeneca, Bristol-Myers Squibb, GSK, Merck & Co., Mylan, Novartis, Pfizer, Sanofi & Valeant Pharmaceuticals Dominating (MTO)

2015-02-26@15:15:00 ET
ALLY Trial Demonstrates 97% Hepatitis C Cure Rates Among Patients Coinfected with HIV After Ribavirin-Free Investigational 12-Week Regimen of Daclatasvir and Sofosbuvir (BIZ)

2015-02-26@12:52:38 ET
Exelixis Announces Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update (ABW)

2015-02-26@11:49:29 ET
Form 144: Filing to Sell 3880 Shares of Bristol-Myers Squibb Co (BMY) (VKR)

2015-02-26@10:31:01 ET
Form 144: Filing to Sell 3880 Shares of Bristol-Myers Squibb Co (BMY) (VKR)

2015-02-26@08:47:37 ET
Form 144: Filing to Sell 3880 Shares of Bristol-Myers Squibb Co (BMY) (VKR)

2015-02-26@08:30:01 ET
Study of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results in Preventing Viral Replication via Different Mechanism of Action Than Current Therapies (BIZ)

2015-02-26@08:19:16 ET
Rigel and Bristol-Myers collaborate to develop cancer immunotherapies (DTM)

2015-02-26@08:00:07 ET
Aduro Biotech Collaborates with Leaders in Cancer Research on Investigator-Sponsored Phase 2 Trial Combining Aduro's Innovative Immunotherapies with Anti-PD-1 Technology to Treat Patients with Advanced Pancreatic Cancer (BIZ)

2015-02-26@08:00:00 ET
CytomX to Present at Cowen and Company 35th Annual Health Care Conference (PRN)

2015-02-26@07:01:01 ET
Dementia Therapeutics Pipeline Review 2015 - 33 Companies & 56 Drug Profiles (MTO)

2015-02-26@07:00:51 ET
Pulmonary Fibrosis Therapeutics Pipeline Review 2015 - 56 Companies (MTO)

2015-02-26@07:00:00 ET
Rigel Pharmaceuticals Collaboration Agreement Initiates Analyst Report Issued by BrokerBank Securities, Inc. (PRN)